ERIC LEACH-RODRIGUEZ DE ARRIBA: Open Payments
NPI 1902008550 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$649 in 23 payments from 7 companies in 2025. Trend: 2023 $996 · 2024 $664 · 2025 $649
Food & beverage: $649
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 12 | $342 |
| Gilead Sciences, Inc. | 4 | $118 |
| Merck Sharp & Dohme LLC | 2 | $65 |
| EMD Serono, Inc. | 2 | $58 |
| Antares Pharma, Inc. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: DOVATO, APRETUDE, PIFELTRO, CABENUVA, XYOSTED, REXULTI, AIRSUPRA.
Industry payments across NY — which companies pay providers there.
